NCT05966727View on ClinicalTrials.gov

Exploratory Evaluation of the Effect of Cholestyramine on Serum Levels of POPs in Obese Female Patients

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 19, 2025

Primary Completion Date

June 19, 2026

Study Completion Date

June 19, 2026

Conditions
Obesity, AbdominalDiabetesBariatric Surgery Candidate
Interventions
DRUG

Cholestyramine Powder

Bile salt chelating resin, used as a lipid-lowering treatment.

Trial Locations (1)

06300

RECRUITING

CHU Nice - Hôpital de l'Archet 2, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER